Medicine Man Technologies, Inc. (SHWZ)
OTCMKTS · Delayed Price · Currency is USD
0.00001
0.00 (0.00%)
Aug 27, 2026, 4:00 PM EST

Medicine Man Technologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-59.68-34.55-18.4714.52-19.42-16.98
Depreciation & Amortization
22.1820.9310.668.580.480.06
Other Amortization
10.810.219.17---
Loss (Gain) From Sale of Assets
1.971.974.68-0.24--
Asset Writedown & Restructuring Costs
1.81.88.01---
Loss (Gain) From Sale of Investments
0.37-00.04-0.220.131.79
Stock-Based Compensation
1.213.590.815.048.237.18
Other Operating Activities
5.46-6.29-9.88-15.06-2.463.66
Change in Accounts Receivable
2.750.93-0.110.240.87-3.36
Change in Inventory
11.684.570.79-4.70.78-0.2
Change in Accounts Payable
-2.37-3.2411.850.491.611.24
Change in Unearned Revenue
----0.050.05-
Change in Income Taxes
19.1417.935.272.03-0-0.58
Change in Other Net Operating Assets
-8.73-5.66-16.13-2.23-0.08-0.38
Operating Cash Flow
6.5912.26.698.4-9.8-7.55
Operating Cash Flow Growth
-71.38%82.26%-20.28%---

Investing Activities

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Capital Expenditures
-5.31-7.87-14.01-5.64-0.77-0.2
Cash Acquisitions
--15.83-58.98-75.68-33.28-
Sale (Purchase) of Intangibles
-2.75-2.75--0.03--
Investment in Securities
---2---
Other Investing Activities
00.01-0.180.83-0.92
Investing Cash Flow
-8.06-26.44-74.99-81.16-33.22-1.12

Financing Activities

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Short-Term Debt Issued
----5-
Long-Term Debt Issued
---132.5213.9-
Total Debt Issued
---132.5218.9-
Short-Term Debt Repaid
----4.87--
Long-Term Debt Repaid
--5.35-0.13---
Total Debt Repaid
-5.61-5.35-0.13-4.87--
Net Debt Issued (Repaid)
-5.61-5.35-0.13127.6518.9-
Issuance of Common Stock
--0.9850.281320.2
Other Financing Activities
-0.13-0.11----
Financing Cash Flow
-6.14-5.460.84177.9431.920.2

Net Cash Flow

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Miscellaneous Cash Flow Adjustments
0--0-0-
Net Cash Flow
-7.61-19.7-67.45105.17-11.1211.53

Free Cash Flow

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Free Cash Flow
1.284.34-7.312.76-10.57-7.75
Free Cash Flow Growth
-87.92%-----
Free Cash Flow Margin
0.73%2.51%-4.59%2.54%-44.03%-73.02%
Free Cash Flow Per Share
0.020.07-0.140.03-0.26-0.23
Levered Free Cash Flow
22.3710.62-15.2635.09-5.671.1
Unlevered Free Cash Flow
32.2720.45-5.5939.48-5.651.2

Additional Metrics

Fiscal Year
TTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash Interest Paid
15.9217.915.245.760.040.19
Cash Income Tax Paid
1.5512.342.1-0.27
Change in Working Capital
22.4714.541.67-4.223.24-3.27